Abstract
Cardiac hypertrophy is the strongest predictor of the development of heart failure, and anti-hypertrophic treatment holds the key to improving the clinical syndrome and increasing the survival rates for heart failure. The paraoxonase (PON) gene cluster (PC) protects against atherosclerosis and coronary artery diseases. However, the role of PC in the heart is largely unknown. To evaluate the roles of PC in cardiac hypertrophy, transgenic mice carrying the intact human PON1, PON2, and PON3 genes and their flanking sequences were studied. We demonstrated that the PC transgene (PC-Tg) protected mice from cardiac hypertrophy induced by Ang II; these mice had reduced heart weight/body weight ratios, decreased left ventricular wall thicknesses and increased fractional shortening compared with wild-type (WT) control. The same protective tendency was also observed with an Apoe -/- background. Mechanically, PC-Tg normalized the disequilibrium of matrix metalloproteinases (MMPs)/tissue inhibitors of MMPs (TIMPs) in hypertrophic hearts, which might contribute to the protective role of PC-Tg in cardiac fibrosis and, thus, protect against cardiac remodeling. Taken together, our results identify a novel anti-hypertrophic role for the PON gene cluster, suggesting a possible strategy for the treatment of cardiac hypertrophy through elevating the levels of the PON gene family.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Deakin, S.P., Bioletto, S., Bochaton-Piallat, M.L., and James, R.W. (2011). HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radic Biol Med 50, 102–109.
Devarajan, A., Bourquard, N., Hama, S., Navab, M., Grijalva, V.R., Morvardi, S., Clarke, C.F., Vergnes, L., Reue, K., Teiber, J.F., and Reddy, S.T. (2011). Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid Redox Signal 14, 341–351.
Frey, N., Katus, H.A., Olson, E.N., and Hill, J.A. (2004). Hypertrophy of the heart: a new therapeutic target? Circulation 109, 1580–1589.
Furlong, C.E., Marsillach, J., Jarvik, G.P., and Costa, L.G. (2016). Paraoxonases-1, -2 and -3: What are their functions? Chem Biol Interact doi: 10.1016/j.cbi.2016.05.036.
Gardin, J.M., and Lauer, M.S. (2004). Left ventricular hypertrophy: the next treatable, silent killer? JAMA 292, 2396–2398.
Givvimani, S., Tyagi, N., Sen, U., Mishra, P.K., Qipshidze, N., Munjal, C., Vacek, J.C., Abe, O.A., and Tyagi, S.C. (2010). MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch Physiol Biochem 116, 63–72.
Heymans, S., Lupu, F., Terclavers, S., Vanwetswinkel, B., Herbert, J.M., Baker, A., Collen, D., Carmeliet, P., and Moons, L. (2005a). Loss or inhibition of uPA or MMP-9 attenuates LVremodeling and dysfunction after acute pressure overload in mice. Am J Pathol 166, 15–25.
Heymans, S., Schroen, B., Vermeersch, P., Milting, H., Gao, F., Kassner, A., Gillijns, H., Herijgers, P., Flameng, W., Carmeliet, P., Van de Werf, F., Pinto, Y.M., and Janssens, S. (2005b). Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 112, 1136–1144.
Li, L., Zhang, H.N., Chen, H.Z., Gao, P., Zhu, L.H., Li, H.L., Lv, X., Zhang, Q.J., Zhang, R., Wang, Z., She, Z.G., Zhang, R., Wei, Y.S., Du, G.H., Liu, D.P., and Liang, C.C. (2011). SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 108, 1180–1189.
Luo, Y.X., Tang, X., An, X.Z., Xie, X.M., Chen, X.F., Zhao, X., Hao, D.L., Chen, H.Z., and Liu, D.P. (2016). Sirt4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. Eur Heart J doi: 10.1093/eurheartj/ehw138.
Mackness, B., Durrington, P.N., and Mackness, M.I. (2002). The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 13, 357–362.
Mann, D.L., and Spinale, F.G. (1998). Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. Circulation 98, 1699–1702.
Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltran, R., Joven, J., and Camps, J. (2008). Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med 45, 146–157.
Ng, C.J., Bourquard, N., Grijalva, V., Hama, S., Shih, D.M., Navab, M., Fogelman, A.M., Lusis, A.J., Young, S., and Reddy, S.T. (2006). Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem 281, 29491–29500.
Ng, C.J., Shih, D.M., Hama, S.Y., Villa, N., Navab, M., and Reddy, S.T. (2005). The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 38, 153–163.
Obineche, E.N., Frossard, P.M., and Bokhari, A.M. (2001). An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 24, 635–639.
Primo-Parmo, S.L., Sorenson, R.C., Teiber, J., and La Du, B.N. (1996). The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498–507.
Roten, L., Nemoto, S., Simsic, J., Coker, M.L., Rao, V., Baicu, S., Defreyte, G., Soloway, P.J., Zile, M.R., and Spinale, F.G. (2000). Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice. J Mol Cell Cardiol 32, 109–120.
Sag, C.M., Santos, C.X., and Shah, A.M. (2014). Redox regulation of cardiac hypertrophy. J Mol Cell Cardiol 73, 103–111.
Satoh, K., Nigro, P., Zeidan, A., Soe, N.N., Jaffre, F., Oikawa, M., O'Dell, M.R., Cui, Z., Menon, P., Lu, Y., Mohan, A., Yan, C., Blaxall, B.C., and Berk, B.C. (2011). Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31, 1116–1123.
She, Z.G., Zheng, W., Wei, Y.S., Chen, H.Z., Wang, A.B., Li, H.L., Liu, G., Zhang, R., Liu, J.J., Stallcup, W.B., Zhou, Z., Liu, D.P., and Liang, C.C. (2009). Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res 104, 1160–1168.
Shih, D.M., Gu, L., Xia, Y.R., Navab, M., Li, W.F., Hama, S., Castellani, L.W., Furlong, C.E., Costa, L.G., Fogelman, A.M., and Lusis, A.J. (1998). Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394, 284–287.
Shih, D.M., Yu, J.M., Vergnes, L., Dali-Youcef, N., Champion, M.D., Devarajan, A., Zhang, P., Castellani, L.W., Brindley, D.N., Jamey, C., Auwerx, J., Reddy, S.T., Ford, D.A., Reue, K., and Lusis, A.J. (2015). PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis. FASEB J 29, 1185–1197.
Spinale, F.G. (2007). Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87, 1285–1342.
Tang, W.H., Wu, Y., Mann, S., Pepoy, M., Shrestha, K., Borowski, A.G., and Hazen, S.L. (2011). Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure. Circ Heart Fail 4, 59–64.
Wang, F., Chen, H., Yan, Y., Liu, Y., Zhang, S., and Liu, D. (2016). Baicalein protects against the development of angiotensin II-induced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling. Sci China Life Sci doi: 10.1007/s11427-015-0277-8.
Wang, Y.X., da Cunha, V., Martin-McNulty, B., Vincelette, J., Li, W., Choy, D.F., Halks-Miller, M., Mahmoudi, M., Schroeder, M., Johns, A., Light, D.R., and Dole, W.P. (2005). Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice. Eur J Pharmacol 512, 215–222.
Zhou, S., Chen, H.Z., Wan, Y.Z., Zhang, Q.J., Wei, Y.S., Huang, S., Liu, J.J., Lu, Y.B., Zhang, Z.Q., and Yang, R.F. (2011). Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 109, 639–648.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at springerlink.fh-diploma.de
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Electronic supplementary material
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Pei, JF., Yan, YF., Tang, X. et al. Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice. Sci. China Life Sci. 59, 1115–1122 (2016). https://doi.org/10.1007/s11427-016-0131-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0131-4